T18	Exp 334 336	it
T19	Exp 221 225	that
T20	Exp 277 281	that
T21	Exp 200 220	the signaling events
T22	Exp 268 276	the fact
T23	Exp 357 382	the relative contribution
T24	Exp 425 432	the TCR
T25	Exp 460 462	we
T26	Exp 622 624	we
T27	Exp 494 498	that
T28	Exp 478 493	the observation
T29	Exp 551 576	the CD28 surface molecule
T30	Exp 580 591	the absence
T31	Exp 651 663	the response
T32	Exp 446 458	this problem
T33	Exp 734 736	we
T34	Exp 746 750	that
T35	Exp 840 844	that
T36	Exp 721 732	this system
T37	Exp 969 973	that
T38	Exp 1120 1127	the TCR
T39	Exp 1208 1221	the induction
T40	Exp 1308 1310	we
T41	Exp 1324 1346	the signaling pathways
T42	Exp 1359 1386	the CD28-mediated induction
T43	Exp 1424 1428	that
T44	Exp 1532 1575	the phosphatidylinositol 3-kinase inhibitor
T45	Exp 1713 1717	that
T46	Exp 1852 1856	that
T47	Exp 1694 1704	These data
T48	Exp 1857 1870	this response
R5	Coref Anaphora:T19 Antecedent:T21
R6	Coref Anaphora:T20 Antecedent:T22
R7	Coref Anaphora:T27 Antecedent:T28
R8	Coref Anaphora:T35 Antecedent:T49
T1	Protein 67 71	CD28
T2	Protein 132 155	acidic sphingomyelinase
T3	Protein 233 237	CD28
T4	Protein 282 286	CD28
T5	Protein 386 390	CD28
T6	Protein 555 559	CD28
T7	Protein 685 689	CD28
T8	Protein 751 755	CD28
T9	Protein 771 773	B7
T10	Protein 879 883	IL-2
T11	Protein 974 976	B7
T12	Protein 1181 1185	CD28
T13	Protein 1263 1267	IL-2
T14	Protein 1363 1367	CD28
T15	Protein 1496 1519	acidic sphingomyelinase
T16	Protein 1747 1751	CD28
T17	Protein 1881 1904	acidic sphingomyelinase
T49	Exp 832 839	T cells
